May 08, 2018

Farmak JSC remains the leader of the domestic medicines market by results of Q1 2018

Farmak JSC  increased its medicine sales by 18.35%

Farmak JSC   increased sales of medicines  by 18.35%

According to the results of Q1 2018, Farmak JSC increased its sales by 18.35% to 1.1 billion UAH against Q1 2017. Proxima Research data.

“For eight years straight now Farmak has been the leader on the pharmaceutical market of the country*. The company has achieved such results due to quality and innovation. Over the past seven years Farmak has spent 2.8 billion hryvnyas on the development and modernization of production. Today, all the equipment of the Company is high-tech and ultra-modern. Production lines meet GMP, ISO requirements. Farmak’s focus is the manufacture of innovative biotech products. These include Flenox, insulin and its analogues, X-ray contrast agents. At the same time, we continue to produce basic drugs that have been on the market for a few decades,” said Volodymyr Kostiuk, acting Executive Director of Farmak JSC.

Back to the Awards